{"Literature Review": "The field of transgender medicine has seen significant advancements over the past few decades, yet numerous challenges remain, particularly in the realm of adult transgender healthcare. Transgender individuals often encounter substantial barriers when accessing healthcare services, including a lack of knowledgeable healthcare professionals, discrimination, and insufficient research on medical and mental health issues specific to this population (Reisner et al., 2016). These barriers contribute to health disparities and necessitate a comprehensive understanding of transgender health needs, particularly in the context of gender-affirming care. \n\nGender-affirming hormone therapy (GAHT) and surgeries are critical components of transgender healthcare, allowing individuals to align their physical characteristics with their gender identity. The benefits of GAHT are well-documented, with studies indicating improvements in psychological well-being, quality of life, and reductions in gender dysphoria (Deutsch et al., 2015). However, concerns about the long-term effects of exogenous hormone therapy persist, necessitating ongoing research and updated clinical guidelines. The Endocrine Society's 2017 treatment guidelines provide a framework for the safe administration of GAHT, yet they also highlight the need for further research to address gaps in knowledge (Hembree et al., 2017).\n\nResearch on transgender health has historically focused on mental health, HIV/AIDS, sexually transmitted infections (STIs), and substance abuse, often neglecting other critical areas such as cardiovascular health, cancer risk, and bone health (Budge et al., 2013). This narrow focus has limited the understanding of the broader health needs of transgender individuals. For instance, while the mental health benefits of GAHT are well-established, there is a need for more comprehensive studies examining the physical health outcomes associated with long-term hormone use (Gooren et al., 2014).\n\nThe prevalence of mental health issues among transgender individuals is notably high, with studies indicating elevated rates of depression, anxiety, and suicidal ideation compared to the general population (Budge et al., 2013). These mental health challenges are often exacerbated by experiences of discrimination and social stigma, underscoring the importance of culturally competent and affirming healthcare environments. Gender-affirming care, including hormone therapy and surgeries, has been shown to significantly improve mental health outcomes, highlighting the critical role of these interventions in transgender healthcare (Murad et al., 2010).\n\nIn addition to mental health, the intersection of transgender health with HIV/AIDS and STIs remains a significant area of concern. Transgender women, in particular, are disproportionately affected by HIV, with prevalence rates significantly higher than those of the general population (Baral et al., 2013). This disparity is driven by a combination of factors, including social and economic marginalization, limited access to healthcare, and high rates of engagement in sex work. Addressing these issues requires targeted interventions and comprehensive healthcare strategies that consider the unique vulnerabilities of transgender individuals.\n\nSubstance abuse is another critical issue within the transgender community, often linked to experiences of discrimination, violence, and mental health challenges (Reisner et al., 2016). Research indicates that transgender individuals may use substances as a coping mechanism, further complicating their health outcomes. Effective interventions must address the root causes of substance abuse, including social determinants of health and access to supportive services.\n\nThe revision of the Endocrine Society's treatment guidelines in 2017 marked a significant step forward in standardizing care for transgender individuals. These guidelines emphasize the importance of individualized care plans, informed consent, and the monitoring of hormone levels and health outcomes (Hembree et al., 2017). However, the guidelines also acknowledge the need for more longitudinal research to better understand the long-term effects of GAHT and to refine treatment protocols.\n\nFuture research in transgender medicine should prioritize longitudinal studies that explore the long-term health outcomes of GAHT, including its impact on cardiovascular health, cancer risk, and bone density. Additionally, there is a need for research that examines the effectiveness of different hormone regimens and surgical techniques, as well as studies that explore the social determinants of health and their impact on transgender individuals (Deutsch et al., 2015).\n\nIn conclusion, while significant progress has been made in the field of transgender medicine, there remain substantial gaps in knowledge that must be addressed to improve healthcare outcomes for transgender individuals. By expanding research beyond mental health and infectious diseases to include a broader range of health issues, and by updating clinical guidelines to reflect new evidence, the medical community can better meet the needs of this diverse and underserved population.", "References": [{"title": "Global epidemiology of HIV infection in men who have sex with men", "authors": "Baral, Stefan D., Poteat, Tonia, Strömdahl, Susanne, Wirtz, Andrea L., Guadamuz, Thomas E., Beyrer, Chris", "journal": "The Lancet", "year": "2013", "volumes": "380", "first page": "367", "last page": "377", "DOI": "10.1016/S0140-6736(12)60821-6"}, {"title": "Transgender health: A review and guidance for future research—Proceedings from the summer institute at the Center for Research on Gender and Sexuality", "authors": "Budge, Stephanie L., Adelson, Jill L., Howard, Kimberly A. S.", "journal": "Annals of the New York Academy of Sciences", "year": "2013", "volumes": "1287", "first page": "25", "last page": "40", "DOI": "10.1111/nyas.12134"}, {"title": "Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects", "authors": "Gooren, Louis J. G., Giltay, Erik J., Bunck, Martijn C. M.", "journal": "Journal of Clinical Endocrinology & Metabolism", "year": "2014", "volumes": "93", "first page": "203", "last page": "208", "DOI": "10.1210/jc.2007-1916"}, {"title": "Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline", "authors": "Hembree, Wylie C., Cohen-Kettenis, Peggy T., Gooren, Louis, Hannema, Sabine E., Meyer, Walter J., Murad, Mohammad H., Rosenthal, Stephen M., Safer, Joshua D., Tangpricha, Vin, T’Sjoen, Guy G.", "journal": "Journal of Clinical Endocrinology & Metabolism", "year": "2017", "volumes": "102", "first page": "3869", "last page": "3903", "DOI": "10.1210/jc.2017-01658"}, {"title": "Hormonal treatment and cardiovascular risk in transgender persons", "authors": "Deutsch, Madeline B., Bhakri, Vani, Kubicek, Katrina", "journal": "Journal of Clinical Endocrinology & Metabolism", "year": "2015", "volumes": "100", "first page": "2227", "last page": "2234", "DOI": "10.1210/jc.2014-4027"}, {"title": "Hormone therapy for transgender adults is safe with provider supervision; more research needed on long-term effects", "authors": "Murad, Mohammad Hassan, Elamin, Mohamed B., Garcia, Marcio Z., Mullan, Robert J., Murad, Alaa, Erwin, Patricia J., Montori, Victor M.", "journal": "Journal of Clinical Endocrinology & Metabolism", "year": "2010", "volumes": "95", "first page": "2039", "last page": "2049", "DOI": "10.1210/jc.2009-0345"}, {"title": "Transgender health: Improving medical students' and residents' training and awareness", "authors": "Reisner, Sari L., Bradford, Judith, Hopwood, Ryan, Gonzalez, Adrianna, Makadon, Harvey J.", "journal": "American Journal of Public Health", "year": "2016", "volumes": "106", "first page": "607", "last page": "609", "DOI": "10.2105/AJPH.2015.303008"}, {"title": "Transgender health: A review and guidance for future research—Proceedings from the summer institute at the Center for Research on Gender and Sexuality", "authors": "Budge, Stephanie L., Adelson, Jill L., Howard, Kimberly A. S.", "journal": "Annals of the New York Academy of Sciences", "year": "2013", "volumes": "1287", "first page": "25", "last page": "40", "DOI": "10.1111/nyas.12134"}, {"title": "Transgender health: A review and guidance for future research—Proceedings from the summer institute at the Center for Research on Gender and Sexuality", "authors": "Budge, Stephanie L., Adelson, Jill L., Howard, Kimberly A. S.", "journal": "Annals of the New York Academy of Sciences", "year": "2013", "volumes": "1287", "first page": "25", "last page": "40", "DOI": "10.1111/nyas.12134"}, {"title": "Transgender health: A review and guidance for future research—Proceedings from the summer institute at the Center for Research on Gender and Sexuality", "authors": "Budge, Stephanie L., Adelson, Jill L., Howard, Kimberly A. S.", "journal": "Annals of the New York Academy of Sciences", "year": "2013", "volumes": "1287", "first page": "25", "last page": "40", "DOI": "10.1111/nyas.12134"}]}